PARAMOUNT trial (Q645)

From JSTOR Labs Wikibase
Revision as of 19:17, 27 August 2019 by Admin (talk | contribs) (‎Created a new Item: adding a new item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
clinical trial studying non-small-cell lung carcinoma
  • A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed plus Best Supportive Care versus Best Supportive Care Immediately Following Induction Treatment with Pemetrexed + Cisplatin
Language Label Description Also known as
English
PARAMOUNT trial
clinical trial studying non-small-cell lung carcinoma
  • A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed plus Best Supportive Care versus Best Supportive Care Immediately Following Induction Treatment with Pemetrexed + Cisplatin

Statements

 

Sitelinks

              Retrieved from "https://kg.jstor.org/w/index.php?title=Item:Q645&oldid=1180"